Clinical Trial Update: PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin [Phase 2]

View source ↗

Summary

Phase 2 trial comparing dabigatran, with and without aspirin, to warfarin for stroke prevention in atrial fibrillation; results have been posted after completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Aspirin (Aspirin)
• Dabigatran (Dabigatran etexilate)
• Warfarin (warfarin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED | Results posted: 2011-02-10